What Makes Some Cell-Penetrating Peptides Effective at Delivering mRNA While Others Fail | Research

The takeaway

Only cell-penetrating peptides with amphipathic (dual water/fat-loving) structural motifs successfully delivered mRNA into cell interiors, while strategies like histidine incorporation and oligomerization alone were insufficient.

Amphipathic motifs required
Only CPPs with membrane-interacting amphipathic structures delivered mRNA to the cytosol — histidine, oligomerization, and amino acid swaps alone all failed

What the researchers found

Systematic engineering of a human lactoferrin-derived CPP revealed that amphipathic sequence motifs are the critical structural determinant for cytosolic mRNA delivery.

Neither histidine incorporation (to promote the proton sponge effect for endosomal escape), nor arginine-to-lysine/ornithine substitutions, nor disulfide-mediated oligomerization were sufficient to convert an uptake-only CPP into a delivery-active one — despite all modified peptides showing cellular uptake. Only the transfer of amphipathic motifs from the delivery-active PepFect14 achieved functional mRNA delivery, with some additional benefit from oligomerization.

Why it matters

mRNA therapeutics — including vaccines and gene therapies — depend on getting mRNA past cell membranes and out of endosomes. Cell-penetrating peptides are a promising delivery vehicle, but the field has lacked clear rules for what makes a CPP effective. This study identifies amphipathic structure as the key requirement, providing a design principle that could guide development of more effective peptide-based delivery systems.

How the study worked

Researchers started with a human lactoferrin-derived CPP that enters cells but cannot deliver cargo to the cytosol. They systematically incorporated structural modifications: histidine residues (to test proton sponge effects), amino acid substitutions mimicking PepFect14, and disulfide-mediated polymerization. Each variant was tested for polyplex stability (using heparin displacement assays), cellular uptake, and functional mRNA delivery activity.

What this study cannot tell us

This is an in vitro cell culture study; in vivo delivery efficiency and biodistribution were not assessed. The findings are primarily based on modifications of one specific CPP scaffold (human lactoferrin), and the design rules may not fully generalize to all CPP families. Functional mRNA delivery was assessed but detailed quantification of delivery efficiency compared to established systems like lipid nanoparticles was not provided.

How to read the evidence

This is a mechanistic in vitro study that systematically tests structure-function relationships in CPPs. It provides clear design principles but lacks in vivo validation.

When this study was published

Published in 2023, this study is recent and contributes to the rapidly evolving field of peptide-based nucleic acid delivery.

The bigger picture

The success of COVID-19 mRNA vaccines demonstrated the transformative potential of mRNA therapeutics, but those vaccines rely on lipid nanoparticles for delivery. Cell-penetrating peptides offer an alternative delivery platform with potentially different advantages in targeting and biocompatibility. Understanding the structural rules governing CPP-mediated delivery — as this study begins to establish — is essential for expanding the peptide delivery toolkit.

Questions still open

Can the amphipathic motif principle be used to rationally design entirely new CPPs for mRNA delivery from scratch?
How do CPP-based mRNA delivery systems compare to lipid nanoparticles in terms of efficiency and safety in animal models?
Do these design rules apply equally to delivering other cargo types like siRNA, plasmid DNA, or proteins?

Common questions

What are cell-penetrating peptides and how do they deliver mRNA?

Cell-penetrating peptides (CPPs) are short chains of amino acids (typically 8–30) that can cross cell membranes. They form complexes with mRNA through electrical charge interactions — the positively charged peptide binds the negatively charged mRNA. These complexes enter cells through endocytosis, but the critical challenge is escaping from endosomes (cellular compartments) to reach the cytosol where mRNA can be translated into protein.

Why is it so hard for CPPs to deliver mRNA effectively?

Most CPPs can get into cells, but they and their cargo get trapped inside endosomes — membrane-bound compartments that act like cellular quarantine zones. Breaking out of endosomes requires the peptide to physically disrupt membranes, which this study shows requires specific amphipathic structural features. Without these features, the mRNA is eventually degraded inside the endosome and never reaches the cell's protein-making machinery.

Read the original research

Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery.

Bioconjugate chemistry, 34(10), 1822-1834

View on PubMed ↗Publisher’s paper ↗

Citation

Egberink, Rik Oude; van Asbeck, Alexander H; Boswinkel, Milou; Muradjan, Grigor; Dieker, Jürgen; Brock, Roland. (2023). Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery.. Bioconjugate chemistry, 34(10), 1822-1834. https://doi.org/10.1021/acs.bioconjchem.3c00346